Extended right colectomy and ileostomy.
Tube thoracostomy (14-French pigtail) left side.
PICC Line Placement Left thigh skin biopsy   History of Present Illness: The patient is a 79-year-old male with past medical history significant for HTN, hypercholesterolemia, coronary artery disease, atrial fibrillation, premature atrial tachycardia, CHF, anxiety/depression and prior squamous cell cancer of the anus (s/p resection, chemotherapy and radiation -[**2151**])who presents now as a transfer from [**Hospital6 17032**] with CBC and differential concerning for acute leukemia.
He was given 1 Unit of irradiated platelets and platelets rose from 15 to 26.
He also received Hydrea 500mg x 2 doses.
He was started on allopurinol 100mg Po tid.
He was placed on PO Keflex for a few days.
Then at ED, infectious disease team was consulted at OSH and placed him on IV Vancomycin and IV Ancef which he has been getting for last day leading up to his transfer.
Oncologic history is significant for prior squamous cell cancer of the anus that was resected and treated with 5-FU and mitomycin with radiation.
Per OSH records, the patient had been in [**4-/2156**] for a routine visit with his cardiologist and labs at that time (for comparison) showed WBC 4.5 with 62% neutrophils, 1% bands, 11% atypical lymph cells, 17% monocytes, and platelets of 149.
Past Medical History: -Squamous Cell CA of anus ([**2150**], s/p chemotherapy and surgical resection) -Hypertension -Hypercholestrolemia -CHF -Atrial Fibrillation (cardioversions x 2) -taken off Coumadin last month for GI Bleed concerns -Premature Atrial Tachycardia -Colonic Polyps - s/p polypectomy [**3-/2156**] -Anxiety -Depression   Social History: The patient is married and lives on [**Location (un) **] with his wife and daughter.
At Discharge:   Pertinent Results: [**2157-3-12**] 05:10PM   GLUCOSE-99 UREA N-23* CREAT-1.1 SODIUM-134 POTASSIUM-3.6 CHLORIDE-101 TOTAL CO2-24 ANION GAP-13 [**2157-3-12**] 05:10PM   estGFR-Using this [**2157-3-12**] 05:10PM   ALT(SGPT)-13 AST(SGOT)-35 LD(LDH)-459* ALK PHOS-69 TOT BILI-0.8 [**2157-3-12**] 05:10PM   ALBUMIN-2.9* CALCIUM-6.9* PHOSPHATE-2.8 MAGNESIUM-2.1 URIC ACID-10.0* IRON-152 [**2157-3-12**] 05:10PM   calTIBC-186* FERRITIN-418* TRF-143* [**2157-3-12**] 05:10PM   TSH-6.8* [**2157-3-12**] 05:10PM   WBC-40.1* RBC-2.86* HGB-8.9* HCT-26.7* MCV-93 MCH-31.2 MCHC-33.4 RDW-18.0* [**2157-3-12**] 05:10PM   NEUTS-18* BANDS-14* LYMPHS-8* MONOS-10 EOS-1 BASOS-0 ATYPS-0 METAS-7* MYELOS-5* PROMYELO-1* NUC RBCS-5* OTHER-36* [**2157-3-12**] 05:10PM   I-HOS-AVAILABLE [**2157-3-12**] 05:10PM   HYPOCHROM-OCCASIONAL ANISOCYT-1+ POIKILOCY-1+ MACROCYT-OCCASIONAL MICROCYT-OCCASIONAL POLYCHROM-1+ OVALOCYT-OCCASIONAL STIPPLED-OCCASIONAL [**2157-3-12**] 05:10PM   PLT SMR-VERY LOW PLT COUNT-29* [**2157-3-12**] 05:10PM   PT-15.2* PTT-33.2 INR(PT)-1.3* [**2157-3-12**] 05:10PM   FIBRINOGE-234  Brief Hospital Course: In summary, the patient is a 79-year-old male with PMH significant for HTN, CHF, hyperlipidemia, atrial fibrillation, prior squamous cell cancer of anus (s/p resection, chemotherapy and radiation in [**2151**]) and 1 week history of left thigh cellulitis who presented with atypical WBCs, thrombocytopenia and anemia concerning for acute leukemia.
The patient's stool was positive for C. difficile toxin, and he was started on PO vanco and flagyl.
He was given Maalox which offered limited relief.
Upright and supine plain abdominal films were ordered STAT and revealed evidence of free air.
He was given platelets, blood transfusions, an NG tube was placed and he was sent emergently to the operating room.
He was started on levophed prior to transfer to the ICU.
Antibiotics changed to meropenem, IV and PR vanc (c. diff), flagyl, fluconazole.
The duodenal perforation was identified, and 3 drains were placed for wide drainage of a lesser sac abscess.
The patient returned to the ICU, still requiring pressure support.
He had bilateral thoracentesis for effusions.
He was cont on TPN and antibiotics.
Patient had received XRT and alkylating chemotherapy in [**2151**] for his squamous cell cancer of anus which places him at increased risk as well.
He was given Hydrea on the night of admission and this was continued through his hospital course up until XXXXX.
He was consented for treatment and he underwent a 5 day chemotherapy cycle from [**3-16**] until [**2157-3-20**] which he tolerated well.
He required several platelet transfusions for his persistent thrombocytopenia.
IVFs were continued and he was placed on allopurinol.
After admission he was continued on IV Vancomycin.
IV Cefipime was discontinued once he had a swab that confirmed MRSA in his wound and he was placed on MRSA precautions.
Wound dressings were changed daily and a wound care consult was called to help with proper care.
Hydrea therapy was therefore extended after completion of his Dacogen chemotherapy.
He had a positive C.difficile stool study after admission and he was placed on Flagyl and PO Vancomycin was added.
He was given Maalox which offered limited relief.
Upright and supine plain abdominal films were ordered STAT and revealed evidence of free air.
He was given platelets, blood transfusions, an NG tube was placed and he was  sent emergently to the operating room.
He underwent XXXXXXXX and was transferred to the [**Hospital Unit Name 153**] post-operatively.
Patient no longer on anticoagulation due to concerns over falls and bloody stools/GI bleed history when on Vioxx.
He was continued on his usual Toprol and Verapamil for rate control, and initially he was place on Flecainide for rhythm control.
However, after decision was made to start him on chemotherapy and AML confirmed a cardiology consult was called to review best approach to medical management of his atrial fibrillation with minimal drug interactions.
Flecainide was discontinued and he was maintained solely on Toprol and Verapamil which proved to be good rate control up until [**2157-3-21**] when he was experiencing abdominal pains.
To control his rate he was given XXXXXX  by surgical team and continued on telemetry monitoring.
--holding statin for chemotherapy --holding all aspirin/anticaogulation  given his thrombocytopenia --cardiac healthy diet .
--continue ot monitor while on IVFs --will continue Toprol and Lasix, no additional coverage needed  .
He was continued on daily Lasix and his BB.
--continue usual home Fluoxetine dose .
#Prophylaxis: No DVT prophylaxis needed with thrombocytopenia.
Medications on Admission: HOME MEDICATIONS: -Fluoxetine 40mg daily -Lipitor 10mg daily -Verapamil SR 120mg daily -Flecanide 25mg daily -Lasix 20mg [**Hospital1 **] -Toprol 12.5mg daily -KCL -Keflex qid -Centrum Silver MVI once daily -Nystatin Swish and Swallow x 1 week for thrush (day [**7-10**] at time of admission to OSH) .
MEDICATIONS ON TRANSFER: Nystatin Swish and Swallow tid Ancef 2g IV q8hrs Vancomycin 1.5g IV q12hrs Ca Carbonate 500mg PO bid Flagyl 500mg PO tid Allopurinol 100mg Po tid Fluoxetine 40mg PO daily Lipitor 10mg PO daily Verapamil SR 120mg PO daily Flecainide 25mg PO tid Toprol 12.5mg PO daily Centrum Silver MVI daily Zantac 150mg PO daily   Discharge Medications:  Discharge Disposition: Expired  Discharge Diagnosis: Primary: Duodenal perforation with abscess formation C. Diff colitis Bilateral pleural effusions Abdominal fluid collection post-op fluid overload requiring diuresis post-op hypotension requiring pressor support in ICU post-op infection/sepsis treated with IV antibiotics post-op AFIB/RVR .
Secondary: -Squamous Cell CA of anus ([**2150**], s/p chemotherapy and surgical resection) -Hypercholestrolemia -CHF -Atrial Fibrillation (cardioversions x 2) -taken off Coumadin last month for GI Bleed concerns, on flecanide -Colonic Polyps - s/p polypectomy at [**Hospital1 1774**] summer, [**2156**] -appendectomy as child -R. ankle fracture iwth metal pinning many years ago -R. shoulder rotator cuff repair -Surgery for peptic ulcer disease thought related to NSAIDS -medical tx for H.pylori -Anxiety -Depression -MRSA-Left thigh cellulitis   Discharge Condition: Stable Sips of fluid for comfort Pain well controlled with Comfort Medications   Discharge Instructions: Per Hospice Agency Protocol.
